Hologic (HOLX) Competitors $65.72 -1.13 (-1.69%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$65.72 0.00 (-0.01%) As of 07/11/2025 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HOLX vs. DXCM, HQY, HSIC, MASI, MMSI, ALC, AMN, AVNS, PEN, and ZBHShould you be buying Hologic stock or one of its competitors? The main competitors of Hologic include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Masimo (MASI), Merit Medical Systems (MMSI), Alcon (ALC), AMN Healthcare Services (AMN), Avanos Medical (AVNS), Penumbra (PEN), and Zimmer Biomet (ZBH). These companies are all part of the "medical" sector. Hologic vs. Its Competitors DexCom HealthEquity Henry Schein Masimo Merit Medical Systems Alcon AMN Healthcare Services Avanos Medical Penumbra Zimmer Biomet Hologic (NASDAQ:HOLX) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation. Does the media refer more to HOLX or DXCM? In the previous week, Hologic and Hologic both had 19 articles in the media. DexCom's average media sentiment score of 1.43 beat Hologic's score of 0.93 indicating that DexCom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hologic 7 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 15 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, HOLX or DXCM? Hologic has higher earnings, but lower revenue than DexCom. Hologic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHologic$4.03B3.63$789.50M$2.3727.73DexCom$4.03B8.11$576.20M$1.3462.22 Is HOLX or DXCM more profitable? Hologic has a net margin of 13.83% compared to DexCom's net margin of 12.90%. DexCom's return on equity of 30.05% beat Hologic's return on equity.Company Net Margins Return on Equity Return on Assets Hologic13.83% 19.71% 10.87% DexCom 12.90%30.05%10.00% Do institutionals and insiders believe in HOLX or DXCM? 94.7% of Hologic shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 1.9% of Hologic shares are owned by company insiders. Comparatively, 0.3% of DexCom shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more risk and volatility, HOLX or DXCM? Hologic has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.44, meaning that its stock price is 44% more volatile than the S&P 500. Do analysts recommend HOLX or DXCM? Hologic presently has a consensus target price of $78.75, indicating a potential upside of 19.83%. DexCom has a consensus target price of $98.50, indicating a potential upside of 18.15%. Given Hologic's higher probable upside, equities research analysts clearly believe Hologic is more favorable than DexCom.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hologic 0 Sell rating(s) 10 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.47DexCom 0 Sell rating(s) 4 Hold rating(s) 15 Buy rating(s) 3 Strong Buy rating(s) 2.95 SummaryDexCom beats Hologic on 10 of the 16 factors compared between the two stocks. Get Hologic News Delivered to You Automatically Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HOLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOLX vs. The Competition Export to ExcelMetricHologicMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.65B$6.73B$5.56B$9.11BDividend YieldN/A1.29%5.06%4.01%P/E Ratio27.7326.3028.2320.27Price / Sales3.6365.27434.20100.92Price / Cash11.9520.3337.1257.67Price / Book2.984.648.045.49Net Income$789.50M$174.76M$3.19B$250.45M7 Day Performance1.52%-1.00%3.62%4.78%1 Month Performance1.50%0.99%5.98%9.58%1 Year Performance-15.41%5.27%29.39%16.41% Hologic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOLXHologic4.7289 of 5 stars$65.72-1.7%$78.75+19.8%-15.4%$14.65B$4.03B27.737,063News CoverageAnalyst ForecastDXCMDexCom4.821 of 5 stars$82.94+0.0%$98.50+18.8%-26.9%$32.52B$4.03B61.9010,300Positive NewsHQYHealthEquity3.8751 of 5 stars$101.83-0.3%$118.09+16.0%+23.6%$8.81B$1.20B74.333,120Positive NewsAnalyst ForecastInsider TradeHSICHenry Schein3.2867 of 5 stars$73.45-1.6%$79.30+8.0%+12.7%$8.94B$12.67B22.9525,000Positive NewsAnalyst ForecastMASIMasimo4.0518 of 5 stars$162.45-3.1%$191.60+17.9%+45.6%$8.81B$2.09B-17.725,600Positive NewsMMSIMerit Medical Systems4.3239 of 5 stars$91.12-2.6%$109.11+19.7%+8.3%$5.39B$1.36B44.677,400Positive NewsAnalyst ForecastALCAlcon1.934 of 5 stars$86.81-1.1%$106.13+22.2%-4.6%$42.82B$9.91B38.5825,599Analyst RevisionHigh Trading VolumeAMNAMN Healthcare Services4.2341 of 5 stars$21.23-3.1%$32.08+51.1%-57.5%$812.68M$2.98B-4.902,968AVNSAvanos Medical2.834 of 5 stars$11.87-3.9%N/A-43.3%$548.87M$687.80M-1.422,227News CoverageNegative NewsPENPenumbra4.8166 of 5 stars$248.05-1.2%$302.40+21.9%+24.4%$9.61B$1.19B234.014,500News CoverageAnalyst ForecastInsider TradeZBHZimmer Biomet4.9506 of 5 stars$92.58-1.2%$111.33+20.3%-13.6%$18.32B$7.68B20.4817,000Analyst Forecast Related Companies and Tools Related Companies DexCom Alternatives HealthEquity Alternatives Henry Schein Alternatives Masimo Alternatives Merit Medical Systems Alternatives Alcon Alternatives AMN Healthcare Services Alternatives Avanos Medical Alternatives Penumbra Alternatives Zimmer Biomet Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HOLX) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hologic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hologic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
